22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
Please fill out the form below to receive company press releases via email when they occur.* - required fields
We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.